Although tocotrienol treatment did not restore frataxin isoform mRNA expression to the levels of control subjects, in FRDA patients, we found an increase of 16% of total frataxin mRNA expression compared to FRDA patients before treatment. This evidence concerns the gene FXN and Friedreich ataxia.